Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer
Clinical trial NCT04953962 · COMPLETED
Trial details
- NCT number
- NCT04953962
- Sponsor
- CanBas Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-18
- Primary completion
- 2023-04-14
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.